SCHEMBL1990715

SCHEMBL1990715

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2ccc(F)cc2)no1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.58
HDAC6 Q9UBN7 2/20 0.45
HTR1A P08908 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38
KCNH3 Q9ULD8 1/20 0.37
ADRB2 P07550 4/20 0.36
ADRB1 P08588 4/20 0.36
ADRB3 P13945 4/20 0.36
SLC6A3 Q01959 1/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
S1PR1 P21453 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1986905 0.91 GHSR (0.58) GHSRHDAC6HTR1AHRH3L3MBTL1
SCHEMBL1989714 0.90 GHSR (0.72) GHSRHTR1AHRH3L3MBTL1PPARD
SCHEMBL1994337 0.86 GHSR (0.57) GHSRHDAC6L3MBTL1LMNATSHR
SCHEMBL1984223 0.86 GHSR (0.52) GHSRHDAC6HTR1AHRH3L3MBTL1
SCHEMBL1991192 0.84 GHSR (0.52) GHSRHTR1AHRH3LMNATSHR
SCHEMBL1989604 0.84 GHSR (0.51) GHSRHDAC6HTR1AHRH3L3MBTL1
SCHEMBL1990054 0.84 GHSR (0.54) GHSRHTR1AL3MBTL1SLC6A3
SCHEMBL1981207 0.83 GHSR (0.81) GHSRHDAC6HTR1AL3MBTL1KCNH3
SCHEMBL1981210 0.83 GHSR (0.81) GHSRHDAC6HTR1AL3MBTL1KCNH3
SCHEMBL1991318 0.83 GHSR (0.53) GHSRHTR1AHRH3PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885HDAC6 209/4885HTR1A 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.